Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Eric Semler’s TCS Capital Management boosted its stake in $SRSL

Eric Semler’s TCS Capital Management, LLC boosted its position in SRS Labs, Inc. (SRSL) to 760 thousand shares, corresponding to a 5.1% passive stake. According to the firm’s 13F, TCS Capital Management increased its holding by 4% to 725 thousand shares of SRSL at the end of the second quarter, so the firm just slightly added net 35 thousand shares into its position. Since TCS Capital Management passed the 5% passive stake threshold on August 31th, they might have done some other transactions over the period before they finally made the 13G file on September 29th. SRSL was wavering throughout the entire year, and has realized a loss of more than 15% year to date. Now the stock is trading at around $7.

SRSL was in two hedge funds’ portfolio at the end of second quarter. Besides Eric Semler’s TCS Capital Management, Jim Simons’ Renaissance Technologies had 323 thousand shares after decreasing his position by 16% from the previous quarter. Since the stock was priced at less than $10, the two firms actually each invested several millions of dollars.


TCS Capital Management is a New York based-hedge fund. It expertise is in the Technology, Services, and Consumer Goods sector. In the second quarter the firm had a 13F portfolio of more than $210 million.

SRS Labs, Inc. is a Semiconductor Equipment & Materials company which specializes in the development of audio and voice technology solutions. It provides licensable technologies including Surround Sound, Audio Rendering, Voice Processing, and Solutions Suite. Its sales mainly come from Korea, Japan, the Americas, China, and Europe countries.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!